HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial.

HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial.

Little is known regarding HIV disease outcomes among individuals who become infected with HIV while receiving antiretroviral medications for prevention. We compared HIV disease parameters among women who seroconverted while receiving tenofovir-containing oral or vaginal pre-exposure prophylaxis (PrE...

Full description

Bibliographic Details
Main Authors: Sharon A Riddler, Marla Husnik, Gita Ramjee, Anamika Premrajh, Bomkazi Onini Tutshana, Arendevi Pather, Samantha Siva, Nitesha Jeenarain, Gonasagrie Nair, Pearl Selepe, Samuel Kabwigu, Thesla Palanee-Phillips, Ravindre Panchia, Felix Mhlanga, Lisa Levy, Edward Livant, Karen Patterson, Vanessa Elharrar, Jennifer Balkus
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5489164?pdf=render

Internet

http://europepmc.org/articles/PMC5489164?pdf=render

Similar Items